P21-activated kinase in inflammatory and cardiovascular disease
- 2 May 2014
- journal article
- review article
- Published by Elsevier BV in Cellular Signalling
- Vol. 26 (9), 2060-2069
- https://doi.org/10.1016/j.cellsig.2014.04.020
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01HL116976, R21HL112293)
- Marie Curie International Incoming Fellowship (PIIF-GA-2013-626429)
This publication has 172 references indexed in Scilit:
- Mesalamine modulates intercellular adhesion through inhibition of p-21 activated kinase-1Biochemical Pharmacology, 2013
- Glucose‐6‐phosphate dehydrogenase, NADPH, and cell survivalIUBMB Life, 2012
- Defining the molecular role of gp91phox in the immune manifestation of acute allergic asthma using a preclinical murine modelClinical and Molecular Allergy, 2012
- Redesign of the PAK1 Autoinhibitory Domain for Enhanced Stability and Affinity in Biosensor ApplicationsJournal of Molecular Biology, 2011
- NADPH oxidases in cardiovascular disease: insights from in vivo models and clinical studiesBasic Research in Cardiology, 2011
- Development of small-molecule inhibitors of the group I p21-activated kinases, emerging therapeutic targets in cancerBiochemical Pharmacology, 2010
- Computational Design of a PAK1 Binding ProteinJournal of Molecular Biology, 2010
- Characterization of P-Rex1 for its role in fMet-Leu-Phe-induced superoxide production in reconstituted COSphox cellsCellular Signalling, 2010
- Group I p21-activated kinases: Emerging roles in immune function and viral pathogenesisThe International Journal of Biochemistry & Cell Biology, 2010
- PAK thread from amoeba to mammalsJournal of Cellular Biochemistry, 2009